Sialic acids in human health and disease

Crick, 1970, Central dogma of molecular biology, Nature, 227, 561, 10.1038/227561a0

Sharon, 1982, Glycoproteins: research booming on long-ignored ubiquitous compounds, Mol. Cell. Biochem., 42, 167, 10.1007/BF00238511

Rademacher, 1988, Glycobiology, Annu. Rev. Biochem., 57, 785, 10.1146/annurev.bi.57.070188.004033

Varki, 1999

Drickamer, 2006

Schauer, 2000, Achievements and challenges of sialic acid research, Glycoconj. J., 17, 485, 10.1023/A:1011062223612

Angata, 2002, Chemical diversity in the sialic acids and related α-keto acids: an evolutionary perspective, Chem. Rev., 102, 439, 10.1021/cr000407m

Varki, 2007, Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins, Nature, 446, 1023, 10.1038/nature05816

Ilver, 2003, Bacterium–host protein–carbohydrate interactions, Methods Enzymol., 363, 134, 10.1016/S0076-6879(03)01049-8

Lehmann, 2006, Sialic acid-specific lectins: occurrence, specificity and function, Cell. Mol. Life Sci., 63, 1331, 10.1007/s00018-005-5589-y

Vimr, 2004, Diversity of microbial sialic acid metabolism, Microbiol. Mol. Biol. Rev., 68, 132, 10.1128/MMBR.68.1.132-153.2004

Varki, 2006, Siglecs – the major subfamily of I-type lectins, Glycobiology, 16, 1R, 10.1093/glycob/cwj008

Dekan, 1991, Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits, Proc. Natl. Acad. Sci. U. S. A., 88, 5398, 10.1073/pnas.88.12.5398

Gelberg, 1996, In vivo enzymatic removal of α2-6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury, Lab. Invest., 74, 907

Weinhold, 2005, Genetic ablation of polysialic acid causes severe neurodevelopmental defects rescued by deletion of the neural cell adhesion molecule, J. Biol. Chem., 280, 42971, 10.1074/jbc.M511097200

Johnson, 2005, Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion, J. Biol. Chem., 280, 137, 10.1074/jbc.M410216200

El Maarouf, 2006, Use of polysialic acid in repair of the central nervous system, Proc. Natl. Acad. Sci. U. S. A., 103, 16989, 10.1073/pnas.0608036103

Rutishauser, 2008, Polysialic acid in the plasticity of the developing and adult vertebrate nervous system, Nat. Rev. Neurosci., 9, 26, 10.1038/nrn2285

Born, 1985, Unusually high concentrations of sialic acids on the surface of vascular endothelia, Br. J. Exp. Pathol., 66, 543

Ashwell, 1982, Carbohydrate-specific receptors of the liver, Annu. Rev. Biochem., 51, 531, 10.1146/annurev.bi.51.070182.002531

Weigel, 2002, Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors, Biochim. Biophys. Acta, 1572, 341, 10.1016/S0304-4165(02)00318-5

Raju, 2001, Glycoengineering of therapeutic glycoproteins: In vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues, Biochemistry, 40, 8868, 10.1021/bi010475i

Bork, 2007, Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells, FEBS Lett., 581, 4195, 10.1016/j.febslet.2007.07.060

Hamilton, 2007, Glycosylation engineering in yeast: the advent of fully humanized yeast, Curr. Opin. Biotechnol., 18, 387, 10.1016/j.copbio.2007.09.001

Betenbaugh, 2004, Biosynthesis of human-type N-glycans in heterologous systems, Curr. Opin. Struct. Biol., 14, 601, 10.1016/j.sbi.2004.09.001

Miwa, 2004, Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation?, Xenotransplantation, 11, 247, 10.1111/j.1399-3089.2004.00126.x

Martin, 2005, Human embryonic stem cells express an immunogenic nonhuman sialic acid, Nat. Med., 11, 228, 10.1038/nm1181

Hashii, 2007, Study on the quality control of cell therapy products. Determination of N-glycolylneuraminic acid incorporated into human cells by nano-flow liquid chromatography/Fourier transformation ion cyclotron mass spectrometry, J. Chromatogr. A., 1160, 263, 10.1016/j.chroma.2007.05.062

Heiskanen, 2007, N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible, Stem Cells, 25, 197, 10.1634/stemcells.2006-0444

Qian, 2007, Anal. Biochem., 364, 8, 10.1016/j.ab.2007.01.023

Bardor, 2005, Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells, J. Biol. Chem., 280, 4228, 10.1074/jbc.M412040200

Noguchi, 1996, Failure of human immunoresponse to N-glycolylneuraminic acid epitope contained in recombinant human erythropoietin, Nephron, 72, 599, 10.1159/000188946

Zhu, 2002, Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum, Xenotransplantation, 9, 376, 10.1034/j.1399-3089.2002.02138.x

Tangvoranuntakul, 2003, Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid, Proc. Natl. Acad. Sci. U. S. A., 100, 12045, 10.1073/pnas.2131556100

Nguyen, 2005, Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells, J. Immunol., 175, 228, 10.4049/jimmunol.175.1.228

Hokke, 1990, Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N-glycolylneuraminic acid, FEBS Lett., 275, 9, 10.1016/0014-5793(90)81427-P

Bergwerff, 1995, Variation in N-linked carbohydrate chains in different batches of two chimeric monoclonal IgG1 antibodies produced by different murine SP2/0 transfectoma cell subclones, Glycoconj. J., 12, 318, 10.1007/BF00731335

Bloom, 1996, Cell line and site specific comparative analysis of the N-linked oligosaccharides on human ICAM/-1des454-532 by electrospray ionization mass spectrometry, Biochemistry, 35, 1856, 10.1021/bi952354m

Baker, 2001, Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells, Biotechnol. Bioeng., 73, 188, 10.1002/bit.1051

Zhou, 2005, Effect of genetic background on glycosylation heterogeneity in human antithrombin produced in the mammary gland of transgenic goats, J. Biotechnol., 117, 57, 10.1016/j.jbiotec.2005.01.001

Ludwig, 2006, Derivation of human embryonic stem cells in defined conditions, Nat. Biotechnol., 24, 185, 10.1038/nbt1177

Benatuil, 2005, The influence of natural antibody specificity on antigen immunogenicity, Eur. J. Immunol., 35, 2638, 10.1002/eji.200526146

Mengerink, 2001, Glycobiology of sperm–egg interactions in deuterostomes., Glycobiology, 11, 37R, 10.1093/glycob/11.4.37R

DeSouza, 1998, Mucin functions and expression in mammalian reproductive tract tissues, Biochem. Biophys. Res. Commun., 247, 1, 10.1006/bbrc.1998.8407

Chatterji, 2000, Paracrine effects of a uterine agglutinin are mediated via the sialic acids present in the rat uterine endometrium, Mol. Cell. Biochem., 215, 47, 10.1023/A:1026582715752

Velasquez, 2007, Role of sialic acid in bovine sperm-zona pellucida binding, Mol. Reprod. Dev., 74, 617, 10.1002/mrd.20619

Schwarzkopf, 2002, Sialylation is essential for early development in mice, Proc. Natl. Acad. Sci. U. S. A., 99, 5267, 10.1073/pnas.072066199

Altheide, 2006, System-wide genomic and biochemical comparisons of sialic acid biology among primates and rodents: evidence for two modes of rapid evolution, J. Biol. Chem., 281, 25689, 10.1074/jbc.M604221200

Arai, 2002, A novel mutation in the GNE gene and a linkage disequilibrium in Japanese pedigrees, Ann. Neurol., 52, 516, 10.1002/ana.10341

Huizing, 2004, Hypoglycosylation of α-dystroglycan in patients with hereditary IBM due to GNE mutations, Mol. Genet. Metab., 81, 196, 10.1016/j.ymgme.2003.11.012

Martin, 2003, Glycobiology of neuromuscular disorders, Glycobiology, 13, 67R, 10.1093/glycob/cwg077

Penner, 2006, Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy, Biochemistry, 45, 2968, 10.1021/bi0522504

Galeano, 2007, Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine, J. Clin. Invest., 117, 1585, 10.1172/JCI30954

Malicdan, 2007, A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy, Hum. Mol. Genet., 16, 2669, 10.1093/hmg/ddm220

Weiss, 1989, Identification of the metabolic defect in sialuria, J. Biol. Chem., 264, 17635, 10.1016/S0021-9258(19)84615-X

Leroy, 2001, Dominant inheritance of sialuria, an inborn error of feedback inhibition, Am. J. Hum. Genet., 68, 1419, 10.1086/320598

Enns, 2001, Clinical course and biochemistry of sialuria, J. Inherit. Metab. Dis., 24, 328, 10.1023/A:1010588115479

Verheijen, 1999, A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases, Nat. Genet., 23, 462, 10.1038/70585

Kleta, 2003, Biochemical and molecular analyses of infantile free sialic acid storage disease in North American children, Am. J. Med. Genet. A., 120A, 28, 10.1002/ajmg.a.20024

Biancheri, 2002, An Italian severe Salla disease variant associated with a SLC17A5 mutation earlier described in infantile sialic acid storage disease, Clin. Genet., 61, 443, 10.1034/j.1399-0004.2002.610608.x

Seyrantepe, 2003, Molecular pathology of NEU1 gene in sialidosis, Hum. Mutat., 22, 343, 10.1002/humu.10268

Martin, 2002, Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation, J. Biol. Chem., 277, 32930, 10.1074/jbc.M203362200

Wearne, 2006, Use of lectins for probing differentiated human embryonic stem cells for carbohydrates, Glycobiology, 16, 981, 10.1093/glycob/cwl019

Pickup, 1995, Serum sialic acid concentration and coronary heart disease in NIDDM, Diabetes Care, 18, 1100, 10.2337/diacare.18.8.1100

Crook, 1994, Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria, Diabetes Care, 17, 305, 10.2337/diacare.17.4.305

Pönniö, 1999, Serum sialic acid in a random sample of the general population, Clin. Chem., 45, 1842, 10.1093/clinchem/45.10.1842

Afzali, 2003, Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients, J. Nephrol., 16, 540

Jamieson, 1993, Sialyltransferase: a novel acute-phase reactant, Comp. Biochem. Physiol. B, 105, 29, 10.1016/0305-0491(93)90165-2

Appenheimer, 2003, Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase, Glycobiology, 13, 591, 10.1093/glycob/cwg066

Yasukawa, 2005, Inflammation-dependent changes in α2,3-, α2,6-, and α2,8-sialic acid glycotopes on serum glycoproteins in mice, Glycobiology, 15, 827, 10.1093/glycob/cwi068

Gunnarsson, 2007, The acute-phase protein alpha 1-acid glycoprotein (AGP) induces rises in cytosolic Ca2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs), FASEB J., 21, 4059, 10.1096/fj.07-8534com

Millar, 2001, The sialylation of plasma lipoproteins, Atherosclerosis, 154, 1, 10.1016/S0021-9150(00)00697-3

Tertov, 2001, Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein, Atherosclerosis, 159, 103, 10.1016/S0021-9150(01)00498-1

Romppanen, 2002, Serum sialic acid as a marker of alcohol consumption: effect of liver disease and heavy drinking, Alcohol. Clin. Exp. Res., 26, 1234, 10.1111/j.1530-0277.2002.tb02661.x

Yamashita, 1993, Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency, J. Biol. Chem., 268, 5783, 10.1016/S0021-9258(18)53387-1

Jaeken, 1993, The carbohydrate-deficient glycoprotein syndromes: an overview, J. Inherit. Metab. Dis., 16, 813, 10.1007/BF00714272

Freeze, 2005, Altered glycan structures: the molecular basis of congenital disorders of glycosylation, Curr. Opin. Struct. Biol., 15, 490, 10.1016/j.sbi.2005.08.010

Suzuki, 2005, Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses, Biol. Pharm. Bull., 28, 399, 10.1248/bpb.28.399

Russell, 2005, The genesis of a pandemic influenza virus, Cell, 123, 368, 10.1016/j.cell.2005.10.019

Shinya, 2006, Avian flu: influenza virus receptors in the human airway, Nature, 440, 435, 10.1038/440435a

Stevens, 2006, Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities, J. Mol. Biol., 355, 1143, 10.1016/j.jmb.2005.11.002

Gagneux, 2003, Human-specific regulation of α2-6 linked sialic acids, J. Biol. Chem., 278, 48245, 10.1074/jbc.M309813200

Glaser, 2005, A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity, J. Virol., 79, 11533, 10.1128/JVI.79.17.11533-11536.2005

Stevens, 2006, Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus, Science, 312, 404, 10.1126/science.1124513

Rose, 2006, Respiratory tract mucin genes and mucin glycoproteins in health and disease, Physiol. Rev., 86, 245, 10.1152/physrev.00010.2005

Charland, 1996, Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2, FEMS Immunol. Med. Microbiol., 14, 195, 10.1111/j.1574-695X.1996.tb00287.x

Ngampasutadol, 2008, Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion, J. Immunol., 180, 3426, 10.4049/jimmunol.180.5.3426

Madico, 2007, Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin, J. Immunol., 178, 4489, 10.4049/jimmunol.178.7.4489

Carlin, 2007, Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes, J. Bacteriol., 189, 1231, 10.1128/JB.01155-06

Crocker, 2007, Siglecs and their roles in the immune system, Nat. Rev. Immunol., 7, 255, 10.1038/nri2056

Van Dyken, 2007, Structural and mechanistic features of protein O-glycosylation linked to CD8+ T cell apoptosis, Mol. Cell Biol., 27, 1096, 10.1128/MCB.01750-06

Wuensch, 2000, Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside α2,6-sialyltransferase mRNA forms, Glycobiology, 10, 67, 10.1093/glycob/10.1.67

Oetke, 2006, Sialoadhesin-deficient mice exhibit subtle changes in B- and T-cell populations and reduced immunoglobulin m levels, Mol. Cell. Biol., 26, 1549, 10.1128/MCB.26.4.1549-1557.2006

Liang, 2006, Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments, J. Biol. Chem., 281, 27526, 10.1074/jbc.M605633200

Nan, 2007, Sialidase expression in activated human T lymphocytes influences production of IFN-γ, J. Leukoc. Biol., 81, 284, 10.1189/jlb.1105692

Rosen, 2004, Ligands for L-selectin: homing, inflammation, and beyond, Annu. Rev. Immunol., 22, 129, 10.1146/annurev.immunol.21.090501.080131

Ley, 2003, The role of selectins in inflammation and disease, Trends Mol. Med., 9, 263, 10.1016/S1471-4914(03)00071-6

Dong, 1998, Combined role of P- and E-selectins in atherosclerosis, J. Clin. Invest., 102, 145, 10.1172/JCI3001

Jilma, 2005, The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia, Blood, 105, 2380, 10.1182/blood-2004-09-3752

Tregouet, 2002, Specific haplotypes of the P-selectin gene are associated with myocardial infarction, Hum. Mol. Genet., 11, 2015, 10.1093/hmg/11.17.2015

Gallart, 1997, Anti-Sia-Ib (anti-Gd) cold agglutinins bind the domain NeuNAcα2-3Gal in sialyl Lewisx, sialyl Lewisa, and related carbohydrates on nucleated cells and in soluble cancer-associated mucins, Blood, 90, 1576, 10.1182/blood.V90.4.1576

Kewitz, 1995, Anti-Pr cold agglutinins recognize immunodominant α2,3- or α2,6-sialyl groups on glycophorins, Glycoconj. J., 12, 714, 10.1007/BF00731269

Feizi, 1996, Carbohydrate recognition by Mycoplasma pneumoniae and pathologic consequences, Am. J. Respir. Crit. Care Med., 154, S133, 10.1164/ajrccm/154.4_Pt_2.S133

Kim, 1997, Perspectives on the significance of altered glycosylation of glycoproteins in cancer, Glycoconj. J., 14, 569, 10.1023/A:1018580324971

Chen, 2006, Cell type-specific roles of carbohydrates in tumor metastasis, Methods Enzymol., 416, 371, 10.1016/S0076-6879(06)16024-3

Varki, 2002, Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans, Semin. Thromb. Hemost., 28, 53, 10.1055/s-2002-20564

Stevenson, 2007, Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects, Thromb. Res., 120, S107, 10.1016/S0049-3848(07)70138-X

Ajona, 2004, Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement, Cancer Res., 64, 6310, 10.1158/0008-5472.CAN-03-2328

Rhodes, 1999, Usefulness of novel tumour markers, Ann. Oncol., 10, 118, 10.1023/A:1008369626649

Yin, 2001, Molecular cloning of the CA125 ovarian cancer antigen – identification as a new mucin, MUC16, J. Biol. Chem., 276, 27371, 10.1074/jbc.M103554200

Wahrenbrock, 2006, Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the ‘tip of the iceberg’?, Cancer Res., 66, 2433, 10.1158/0008-5472.CAN-05-3851

Wahrenbrock, 2003, Selectin–mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas, J. Clin. Invest., 112, 853, 10.1172/JCI18882

Varki, 2007, Trousseau's syndrome: multiple definitions and multiple mechanisms, Blood, 110, 1723, 10.1182/blood-2006-10-053736

Malykh, 2001, N-glycolylneuraminic acid in human tumours, Biochimie, 83, 623, 10.1016/S0300-9084(01)01303-7

Yin, 2006, Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells, Cancer Res., 66, 2937, 10.1158/0008-5472.CAN-05-2615

Ju, 2005, Protein glycosylation: chaperone mutation in Tn syndrome, Nature, 437, 1252, 10.1038/4371252a

Ju, 2008, Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc, Cancer Res., 68, 1636, 10.1158/0008-5472.CAN-07-2345

Schnaar, 2004, Glycolipid-mediated cell–cell recognition in inflammation and nerve regeneration, Arch. Biochem. Biophys., 426, 163, 10.1016/j.abb.2004.02.019

Pan, 2005, Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice, Exp. Neurol., 195, 208, 10.1016/j.expneurol.2005.04.017

Yang, 2006, Sialidase enhances spinal axon outgrowth in vivo, Proc. Natl. Acad. Sci. U. S. A., 103, 11057, 10.1073/pnas.0604613103

Simpson, 2004, Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase, Nat. Genet., 36, 1225, 10.1038/ng1460

Yamashita, 2003, Enhanced insulin sensitivity in mice lacking ganglioside GM3, Proc. Natl. Acad. Sci. U. S. A., 100, 3445, 10.1073/pnas.0635898100

Yuki, 2005, Carbohydrate mimicry: a new paradigm of autoimmune diseases, Curr. Opin. Immunol., 17, 577, 10.1016/j.coi.2005.09.004

Hughes, 2005, Guillain-Barré syndrome, Lancet, 366, 1653, 10.1016/S0140-6736(05)67665-9

Chai, 2006, Structural basis of cell surface receptor recognition by botulinum neurotoxin B, Nature, 444, 1096, 10.1038/nature05411

Candelise, 2002, Gangliosides for acute ischemic stroke, Stroke, 33, 2336, 10.1161/01.STR.0000029272.13806.46

Odaka, 2000, Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy, J. Neurol. Sci., 175, 96, 10.1016/S0022-510X(00)00287-2

Yuki, 2004, Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome, Proc. Natl. Acad. Sci. U. S. A., 101, 11404, 10.1073/pnas.0402391101

Rhim, 2001, Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell, Glycoconj. J., 18, 649, 10.1023/A:1020815205022

Xia, 2007, Pseudomonas aeruginosa mucoid strain 8830 binds glycans containing the sialyl-Lewis x epitope, Glycoconj. J., 24, 87, 10.1007/s10719-006-9015-y

Roseman, 2003, The Man/GalNAc-4-SO4-receptor: relating specificity to function, Methods Enzymol., 363, 121, 10.1016/S0076-6879(03)01048-6

Mi, 2008, Ablation of GalNAc-4-sulfotransferase-1 enhances reproduction by altering the carbohydrate structures of luteinizing hormone in mice, J. Clin. Invest., 118, 1815

Erickson, 1994, Streptococcus pneumoniae-induced hemolytic uremic syndrome: a case for early diagnosis, Pediatr. Nephrol., 8, 211, 10.1007/BF00865481

Suzuki, 2008, IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1, J. Clin. Invest., 118, 629

Aspholm, 2006, SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans, PLoS Pathog., 2, e110, 10.1371/journal.ppat.0020110

Shen, 2004, O-Acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma, Eur. J. Biochem., 271, 281, 10.1046/j.1432-1033.2003.03927.x

Corfield, 1999, Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence, Glycoconj. J., 16, 307, 10.1023/A:1007026314792

Grewal, 2008, The Ashwell receptor mitigates the lethal coagulopathy of sepsis, Nat. Med., 14, 648, 10.1038/nm1760

Dimitroff, 2003, Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin, Blood, 101, 602, 10.1182/blood-2002-06-1736

Cheresh, 1984, O-Acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant, Science, 225, 844, 10.1126/science.6206564

Kohla, 2002, Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin, Neurochem. Res., 27, 583, 10.1023/A:1020211714104